Facelift in Palermo Italy
As we become older the gravity, sun exposure and everyday stress leave their marks on our faces. Wrinkles appear between the nose and the mouse, the skin becomes lose and drop below the jaw line and extra fat and skin accumulates around the neck. Facelift cannot stop the aging process but it can "turn back time" by removing extra skin and fat and straitening the muscles.
The ideal candidates for the procedure are patients with skin of the face and neck that started to drop but still has its elasticity.
The operation last from 3-7 hours (it can be longer if additional procedures are done). Some surgeons prefer to work on each side at a time and some do both sides simultaneously. The placement of the cuts and the magnitude of the operation depend on face structure and the correction required. The cut usually starts on the forehead goes in front of the ear and behind the ear lobe, additional cut below the chin is made to repair the neck. The surgeon separates the skin from the fat, removes the extra fat, strengthens the muscles and returns the fat pockets where they use to be. Afterwards he stretches the skin, cuts the extra and closes with sutures. A drainage tube usually left from both sides to draine secretions and blood and the face is bandaged for the first 24 hours.
Every operation has its risks although not common those include, bleeding, infection, damage to facial nerves (usually temporal), face asymmetry and delayed healing. Patients who smoke have higher rates of delayed healing.
There may be pain or uncomfortable felling after the recovery that can be treated with painkillers. A sensation of ants crawling usually disappears after weeks or a month after the surgery. Bandages are removed after a day or two and your face may look swollen. Red or pale with bleeding spots, you must remember that those will disappear after few days or weeks.
You can get out of bed after 24 hours but you should avoid any efforts for at least a week to help the healing process. You should avoid alcohol, hot tubs and saunas for at least a month. Most of the patients feel disappointed at first, their face look and feel strange but after a few weeks the scars will heal and you'll be able to see the final results. Many patients return to work after 3 weeks. Sometimes you may need to use make up to blur the hemorrhage spots.
More Palermo info...
Palermo By bus
Regular, fast buses to Catania, Taormina, Trapani, Enna, Agrigento, and Syracuse. Loads of other places served too.
-
Palermo Mid-range
Hotel Casa Giuditta, Via Savona 10 - Piazza Kalsa, [5]. Casa Giuditta is located in the historical city center of Palermo, in front of the sea,. It offers its guests air-conditioned beautiful rooms and apartments of the 17th century in the centre of the city, near the sea. Fully furnished of all modern commodities, air-condition, washing-machines, kitchen with oven, freezer, and dishwasher, satellite TV. Why choose an hotel if you can have your own apartment at the same price? Do not be a tourist, live as we live! Your children are welcome and we have a baby shop open 24 hours a day. -
Plastic Surgery News...
- The Midlands Therapeutics Review and Advisory Committee (MTRAC) has reviewed the evidence for the use of memantine (Ebixa) and concluded that it is not suitable for prescribing in primary care due to the absence of clear treatment endpoints, and the difficulty in measuring response to treatment.
- According to research published in the Journal of the American Medical Association, there were no significant differences in clinical outcomes between patients receiving sirolimus- and paclitaxel-eluting stents in everyday clinical practice.
Researchers evaluated sirolimus- and paclitaxel-eluting stents for the prevention of symptom-driven clinical end points, using a study design reflecting everyday clinical practice. The SORT OUT II trial involved 2098 patients treated with percutaneous coronary intervention (PCI) and randomised to receive either sirolimus-eluting (n = 1065) or paclitaxel-eluting (n = 1033) stents. Indications for PCI included ST-segment elevation myocardial infarction (STEMI), non-STEMI or unstable angina pectoris, and stable angina. Additionally, dual antiplatelet therapy with aspirin and clopidogrel was recommended for 1 year for all patients. After that period, clopidogrel was discontinued and aspirin continued lifelong, if tolerated.
The primary end point was a composite clinical end point of major adverse cardiac events, defined as either cardiac death, acute myocardial infarction, target lesion revascularisation, or target vessel revascularisation. Secondary end points were individual components of the composite end point, all-cause mortality and stent thrombosis.
The following results were reported:
• With respect to the primary end point, the sirolimus- and the paclitaxel-eluting stent groups did not differ significantly in major adverse cardiac events (98 [9.3%] vs. 114 [11.2%]; hazard ratio, 0.83 [95% confidence interval, 0.63-1.08]; P = 0.16)
• Additionally, no statistically significant differences were reported in stent thrombosis rates, rates of acute myocardial infarction, target lesion or vessel revascularisation, cardiac death or all-cause death
In a related editorial, the authors comment on possible limitations of the study:
1. The study randomised less than a third of the potentially eligible patients, which suggests that the cohort may not be as unselected as the authors had intended for emulating real life practice
2. The study was underpowered due to the small sample size coupled with relatively low event rates